Universal Inosine Template for Random Allelic Series Construction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for large-scale mutagenesis of specific DNA sequences are limited by the need to synthesize numerous oligonucleotides, making it costly and inefficient to produce allelic series with single nucleotide changes, which is essential for understanding protein function and variant interpretation in humans.

Innovation Solution

A method involving linear PCR with universal base triphosphates containing a blocking group, followed by removal of the blocking group and exponential PCR, generates a mutational library with single point mutations evenly distributed throughout the target nucleic acid, eliminating the need for multiple oligonucleotides and reducing costs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If oligonucleotides are synthesized en masse to be used as templates for mutagenesis, then allelic series can be constructed, but the cost and complexity increase significantly

Engineering Contradiction:
Improveaccuracy of single nucleotide mutationVSAvoidnumber of oligonucleotides required
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses a universal base (inosine) that can pair with all four natural bases (A, T, C, G), allowing a single oligonucleotide template to generate all possible single nucleotide mutations at a target position. This eliminates the need for four separate oligonucleotides for each mutation site, reducing the number of components from hundreds to thousands down to a minimal set.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent introduces an intermediary universal base (inosine) that mediates between the oligonucleotide template and the target DNA. This intermediary allows non-specific base pairing during initial annealing, enabling a single template to guide the introduction of multiple different nucleotides through subsequent PCR amplification with normal dNTPs.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If traditional mutagenesis methods are used, then allelic series can be produced, but the production time and cost increase

Engineering Contradiction:
Improvespeed of allelic series productionVSAvoidamount of oligonucleotides to purchase
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

A single universal oligonucleotide template containing inosine at the desired mutation position can generate all four possible single nucleotide variants (A, T, C, G) at that position through PCR amplification. This universal template replaces the need to purchase and handle hundreds of individually synthesized oligonucleotides, dramatically reducing both quantity required and production time.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent performs preliminary annealing of the universal oligonucleotide template to the target DNA before PCR amplification. This preliminary step allows the universal base to establish initial binding, after which standard PCR with normal dNTPs efficiently generates the complete allelic series, separating the template preparation from the mutation generation steps.

Inventive Principle:
Principle #10Preliminary action

3Manufacturing precision

If linear PCR with blocking group is used, then single point mutations are generated, but additional processing steps are required

Engineering Contradiction:
Improvesingle point mutation accuracyVSAvoidnumber of PCR steps
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent extracts the blocking group from the universal base triphosphate before incorporating it into the oligonucleotide template. This removal of the blocking group allows the universal base to be incorporated during linear PCR without preventing subsequent exponential amplification, thereby reducing the number of additional processing steps needed while maintaining single point mutation precision.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for the rapid and cost-effective production of allelic series with single nucleotide changes, improving the interpretation of genetic variants and protein function analysis, while minimizing secondary mutations and size restrictions.

Implementation Method 1

creating a reaction mixture comprising the target nucleic acid, polymerase, a forward primer, deoxynucleotide triphosphates (dNTPs) and universal base triphosphates comprising a blocking group; performing linear PCR, wherein the linear PCR generates products of various lengths, wherein each product comprises about 1 universal base comprising a blocking group, and wherein the linear PCR stops after incorporating the universal base triphosphate comprising a blocking group

Methodology Applied
Scientific EffectDNA polymerase catalysis: Enzyme

Implementation Method 2

dephosphorylating 2′-deoxy, 3′-O—NH2 adenosine triphosphate with a phosphatase

Methodology Applied
Scientific EffectPhosphatase catalysis: Enzyme

Implementation Method 3

deaminating the product from (a) with a deaminase

Methodology Applied
Scientific EffectDeamination: Enzyme

Implementation Method 4

phosphorylating the product from (b) with three different kinases

Methodology Applied
Scientific EffectKinase catalysis: Enzyme

Data Source

PatentUS9868947B2Compositions and methods for the construction of a random allelic series
Publication Date: 2018.01.16 SHRINERS HOSPITALS FOR CRIPPLED CHILDREN
  • US9868947B2 patent drawing
  • US9868947B2 patent drawing
  • US9868947B2 patent drawing

AI summary

The present disclosure provides a method of making a systematic single point mutation in a target nucleic acid and a method of generating a mutational library comprising target nucleic acids with single point mutations. The mutational library comprises target nucleic acids with single point mutations distributed evenly throughout the target nucleic acid.